Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- AltruBio Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06109441
- Locations
- 🇺🇸
San Diego Gastroenterology, San Diego, California, United States
🇺🇸Rocky Mountain Gastroenterology, Littleton, Colorado, United States
🇺🇸Gastro Health Research, Miami, Florida, United States
A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers
- Conditions
- Healthy Volunteers
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- AltruBio Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT05723692
- Locations
- 🇺🇸
ICON Early Development Services, Lenexa, Kansas, United States
Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease
- Conditions
- Treatment-refractory Acute Graft-versus-Host DiseaseSteroid-refractory Acute Graft-versus-Host Disease
- First Posted Date
- 2017-11-01
- Last Posted Date
- 2023-01-19
- Lead Sponsor
- AltruBio Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT03327857
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸David Geffen School of Medicine at UCLA, Los Angeles, California, United States
🇺🇸University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2017-09-29
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- AltruBio Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03298022
- Locations
- 🇺🇸
Lynn Institute of the Ozarks, Little Rock, Arkansas, United States
🇺🇸Stomach Doctor - Surinder Saini, MD - Fountain Valley, Newport Beach, California, United States
🇵🇷Wellness Clinical Research (WCR), Vega Baja, Puerto Rico